Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of Genius Sports Limited (NYSE: GENI) was $8.76 for the day, up 0.46% from the previous closing price of $8.72. In other words, the price has increased by $0.46 from its previous closing price. On the day, 3.96 million shares were traded. GENI stock price reached its highest trading level at $9.05 during the session, while it also had its lowest trading level at $8.75.
Ratios:
Our analysis of GENI’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 29.12 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 230.69. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.50. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On April 16, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $7.50.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 10 ’25 when Davison Jack bought 8,202 shares for $8.73 per share.
Stevens Eric bought 13,736 shares of GENI for $122,157 on Jan 08 ’25. On Jan 08 ’25, another insider, Taylor Nicholas Charles Fraser, who serves as the Officer of the company, bought 8,859 shares for $8.89 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GENI now has a Market Capitalization of 1849586432 and an Enterprise Value of 1777098496. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.35 while its Price-to-Book (P/B) ratio in mrq is 3.33. Its current Enterprise Value per Revenue stands at 3.842 whereas that against EBITDA is -40.043.
Stock Price History:
The Beta on a monthly basis for GENI is 2.16, which has changed by 0.43421054 over the last 52 weeks, in comparison to a change of 0.22677135 over the same period for the S&P500. Over the past 52 weeks, GENI has reached a high of $10.33, while it has fallen to a 52-week low of $4.91. The 50-Day Moving Average of the stock is -1.92%, while the 200-Day Moving Average is calculated to be 25.32%.
Shares Statistics:
GENI traded an average of 2.55M shares per day over the past three months and 2752710 shares per day over the past ten days. A total of 211.14M shares are outstanding, with a floating share count of 188.49M. Insiders hold about 10.73% of the company’s shares, while institutions hold 79.58% stake in the company. Shares short for GENI as of 1735603200 were 30643550 with a Short Ratio of 12.02, compared to 1732838400 on 26469448. Therefore, it implies a Short% of Shares Outstanding of 30643550 and a Short% of Float of 19.780001.
